Business Law and Corporate Law

Subscribe
Business law and corporate law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics that involve business and corporate law produced by specialists working in this area every day.
Video
WOAH: Sonera Just Acquired Blacklist Alliance And Number Verifier– Let The Market Consolidation Battles Commence! (Video)
Sonera, the compliance and deliverability platform formed by DNC.com and Pure CallerID, has acquired Blacklist Alliance and Number Verifier in a major consolidation move. The acquisitions unite list scrubbing, litigator screening, caller identity, and number remediation on a single platform that now processes over 1.8 billion phone numbers monthly. This strategic combination positions Sonera as a dominant force in the regulated outbound engagement market, bringing together two decades of compliance data wit
United States Commercial
Troutman Amin LLP
Article
SEC Proposes Landmark Rescission Of Shareholder Proposal Rule And Reforms To Proxy Solicitation Process
On September 16, 2026, the Securities and Exchange Commission proposed to (1) rescind Rule 14a-8, the federal shareholder proposal rule, and amend Rule 14a-4(c) to expand issuers’ discretionary voting authority with respect to certain shareholder proposals and (2) modernize various aspects of the proxy solicitation framework to reflect developments in market practice and technology. If adopted, the proposals would represent the most significant overhaul of the federal proxy regime in decades.
United States Commercial
ST
Simpson Thacher & Bartlett
Podcast
We Get Privacy — Episode 21: Before You Sign: Negotiating AI Contract Terms That Protect Your Organization (Podcast)
Companies negotiating AI-related contract provisions must balance innovation flexibility with evolving regulatory requirements. Legal experts discuss the AI clauses increasingly appearing in vendor and customer agreements and share practical strategies for negotiating them in alignment with a company's AI governance program.
United States Commercial
JL
Jackson Lewis P.C.
See more
Article
One Year On: The Failure To Prevent Fraud Offence, The Crime And Policing Act 2026, And What MoD Suppliers Must Do Now
September 2026 marks the first anniversary of the corporate criminal offence of failure to prevent fraud coming into force under section 199 of the Economic Crime and Corporate Transparency Act 2023 (ECCTA). The Home Office guidance recommends that organisations review their fraud prevention measures at least every 12 months.
United States Criminal
CM
Crowell & Moring LLP
Article
SEC Proposes Landmark Rescission Of Shareholder Proposal Rule And Reforms To Proxy Solicitation Process
On September 16, 2026, the Securities and Exchange Commission proposed to (1) rescind Rule 14a-8, the federal shareholder proposal rule, and amend Rule 14a-4(c) to expand issuers’ discretionary voting authority with respect to certain shareholder proposals and (2) modernize various aspects of the proxy solicitation framework to reflect developments in market practice and technology. If adopted, the proposals would represent the most significant overhaul of the federal proxy regime in decades.
United States Commercial
ST
Simpson Thacher & Bartlett
See more
Article
One Year On: The Failure To Prevent Fraud Offence, The Crime And Policing Act 2026, And What MoD Suppliers Must Do Now
September 2026 marks the first anniversary of the corporate criminal offence of failure to prevent fraud coming into force under section 199 of the Economic Crime and Corporate Transparency Act 2023 (ECCTA). The Home Office guidance recommends that organisations review their fraud prevention measures at least every 12 months.
United States Criminal
CM
Crowell & Moring LLP
Podcast
We Get Privacy — Episode 21: Before You Sign: Negotiating AI Contract Terms That Protect Your Organization (Podcast)
Companies negotiating AI-related contract provisions must balance innovation flexibility with evolving regulatory requirements. Legal experts discuss the AI clauses increasingly appearing in vendor and customer agreements and share practical strategies for negotiating them in alignment with a company's AI governance program.
United States Commercial
JL
Jackson Lewis P.C.
See more
Article
SEC Proposes Landmark Rescission Of Shareholder Proposal Rule And Reforms To Proxy Solicitation Process
On September 16, 2026, the Securities and Exchange Commission proposed to (1) rescind Rule 14a-8, the federal shareholder proposal rule, and amend Rule 14a-4(c) to expand issuers’ discretionary voting authority with respect to certain shareholder proposals and (2) modernize various aspects of the proxy solicitation framework to reflect developments in market practice and technology. If adopted, the proposals would represent the most significant overhaul of the federal proxy regime in decades.
United States Commercial
ST
Simpson Thacher & Bartlett
Article
SEC Grants Petitions For Review Of Nasdaq’s $5 Million MVLS Listing Standard And Extends Review Period For NYSE American’s Proposed $5 Million Average Market Capitalization Requirement
The SEC has granted petitions for review of Nasdaq's $5 million MVLS listing standard, keeping the controversial rule on hold while extending the review period for NYSE American's similar market capitalization requirement. Microcap companies trading near these thresholds face potential delisting consequences if these proposed rule changes are ultimately approved, making it critical to understand the compliance strategies and ongoing regulatory developments.
United States Finance
B
Bevilacqua
See more
Article
Root Causes: Updates And Insights On Quality And Inspections
The FDA is advancing significant changes to drug manufacturing oversight through proposed PDUFA VIII commitments, new registration pathways for distributed manufacturing, and enhanced inspection protocols. These developments aim to strengthen supply chain transparency, streamline facility readiness assessments, and reinforce good clinical practice standards in an increasingly globalized clinical trial landscape.
United States Healthcare
AP
Arnold & Porter
See more